Deadline: Letter of Intent Required, due March 3, 2015
The program was developed to address the current concerns about an adequate funding base for postdoctoral fellows (MD, MD/PhD and PhD) who specifically direct their research towards translational findings and who will demonstrate how their research will have direct benefits to human aging. Postdoctoral fellows at all levels of training are eligible. Up to ten one-year fellowships will be awarded. The award levels range from $49,000 to $60,000, based on years of relevant experience.
- The applicant must be a postdoctoral fellow (MD and/or PhD degree or equivalent) at the start date of the award (October 1, 2015).
- The proposed research must be conducted at any type of not-for-profit setting in the United States.
- Individuals who are employees in the NIH Intramural program are not eligible.
- Applicants who have received postdoctoral training beyond 5 years (before October 1, 2010) must provide a justification for the additional training period.
- Fellows may not hold any concurrent foundation, not-for-profit or government funding.
Former Ellison/AFAR and Glenn/AFAR postdoctoral fellowship awardees may apply if the criteria above are met.
Learn more about this opportunity
Submit your application for the Tres Cantos Open Lab Foundation: Cofund Fellowship Program by February 4, 2015stdocs, you can advance your research in tuberculosis, malaria, Chagas disease, and leishmaniasis with support from the Tres Cantos Open Lab Foundation (TCOLF) Cofund Fellowship Program. The Fellowship will give you access to GSK’s pharmaceutical expertise and high-throughput facility in Tres Cantos, Spain.
Become a Fellow
If you have a proven interest in these research areas, start by submitting a proposal. The Open Lab Cofund Fellowship is partially funded by the EU through its FP7 Marie Curie co-funding program. Receive all the legal, administrative and industrial support you need. With world-class premises at your disposal, there’s no better place to speed up the development of new treatments for neglected diseases.
Applications are due February 4, 2015.
Get started on your application
Supported by: GSK
This Notice supersedes NOT-OD-15-024 about the NIH and AHRQ requirement for use of a new biosketch format and provides some latitude in the transition for those who have already been compiling biosketches for their large grant applications with deadlines in early in 2015.
NIH and AHRQ encourages applicants to use the newly published biosketch format for all grant and cooperative agreement applications submitted for due dates on or after January 25, 2015, and will require use of the new format for applications submitted for due dates on or after May 25, 2015. Applicants may submit using the new biosketch format for due dates before January 25, 2015, if they wish. – See more at: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-032.html#sthash.ckhi0LBz.dpuf